Somatix deal

SOMA acquired an exclusive license to a family of tumor markers from the Ludwig Institute for Cancer Research. The institute will receive payments to support its research into the proteins, called MAGE-1 antigens. MAGE proteins are some of the few markers expressed by a wide variety of cancer cells that can be targeted by the human immune system, the company said. ...